Lincoln Pharmaceuticals Limited

NSEI:LINCOLN Stock Report

Market Cap: ₹15.5b

Lincoln Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NSEI:LINCOLN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Jun 24Buy₹7,310,250Munjal PatelIndividual13,500₹541.50
03 Jun 24Buy₹19,799,152Munjal PatelIndividual35,000₹568.25
27 Feb 24Sell₹1,484,773Nishitkumar PatelIndividual2,000₹751.27
26 Feb 24Sell₹1,120,935Renukaben PatelIndividual1,500₹747.29
20 Feb 24Sell₹8,067,668Renukaben PatelIndividual11,353₹710.62
16 Feb 24Buy₹12,820,000Anand PatelIndividual20,000₹641.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of LINCOLN?
Owner TypeNumber of SharesOwnership Percentage
State or Government104,5760.522%
Institutions317,9391.59%
Private Companies1,503,8007.51%
General Public7,702,13838.5%
Individual Insiders10,401,27551.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 60.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.4%
Munjal Patel
2,678,800₹2.1b0%no data
11.6%
Ashish Patel
2,329,377₹1.8b9.73%no data
6.52%
Mahendrabhai Patel
1,306,203₹1.0b-20.3%no data
3.78%
Rajnikant Patel
756,801₹584.1m0%no data
2.5%
Sunmed Corporation LLP
500,000₹385.9m0%no data
2.39%
Kishorbhai Shah
478,400₹369.2m0%no data
2.37%
Downtown Travels Pvt Ltd
475,000₹366.6m0%no data
2.11%
Digital Biotech Private Limited
422,800₹326.3m0%no data
1.87%
Hashmukhbhai Patel
373,600₹288.3m0%no data
1.66%
Anand Patel
332,000₹256.2m0%no data
1.33%
Rimo Capital Fund, LP
266,450₹205.6m6.45%27.33%
1.32%
Dheeraj Lohia
263,637₹203.5m0%no data
1.08%
Kamlesh Patel
215,822₹166.6m0%no data
1.03%
Shivani Shah
206,475₹159.3m0%no data
1.01%
Mitesh Parikh
202,871₹156.6m0%no data
1%
Mansi Patel
200,000₹154.4m0%no data
0.88%
Hansaben Patel
177,200₹136.8m0%no data
0.77%
Nishitkumar Patel
153,400₹118.4m0%no data
0.72%
Manguben Patel
145,140₹112.0m0%no data
0.62%
Dharmistha Patel
124,459₹96.1m0%no data
0.55%
Arvindbhai Patel
111,000₹85.7m0%no data
0.53%
Downtown Finance Pvt Ltd
106,000₹81.8m0%no data
0.49%
Renukaben Patel
98,047₹75.7m0%no data
0.43%
Jigar Patel
86,200₹66.5m0%no data
0.41%
Mihirbhai Patel
82,669₹63.8m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 08:31
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lincoln Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research